Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Ginkgo Biloba Extract in the Treatment of Schizophrenia

NCT05258123 is registered in ClinicalTrials.gov with Beijing HuiLongGuan Hospital as lead sponsor.

NCT NCT05258123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05258123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Ginkgo Biloba Extract in the Treatment of Schizophrenia
Lead sponsor
Beijing HuiLongGuan Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2017
Completion date
August 15, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia